- Volume 16 Issue 12
DOI QR Code
Radiofrequency Ablation for Liver Metastases after Transarterial Chemoembolization: A Systemic Analysis
- Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
- Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
- Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University) ;
- Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
- Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
- Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
- Published : 2015.07.13
Background: This systemic analysis was conducted to evaluate tumor recurrence rate and one-year survival rate for patients with liver metastases received radiofrequency ablation after transarterial chemoembolization and introduce a new method of radiofrequency ablation by puncture navigation technology for single liver metastases after transarterial chemoembolization. Materials and Methods: Clinical studies evaluating tumor recurrence rate and one-year survival rate. Appling the innova trackvision software to process one liver metastases received transarterial chemoembolization and using radiofrequency ablation by puncture navigation technology to treat the liver metastases. Results: 3 clinical studies which including 235 patients with liver metastases after transaeterial chemoembolization were considered eligible for inclusion. Systemic analysis suggested that tumor recurrence rate was 23% (54/235), one-year survival rate was 76% (178/235). The new procedure was performed successfully and the patient received a good prognosis. Conclusions: This systemic analysis suggests that radiofrequency ablation is a good method for liver metastases after transarterial chemoembolization and could receive a relatively good prognosis.
Liver metastases;radiofrequency ablation-transarterial chemoembolization
- Bloomston M, Binitie O, Fraiji E, et al (2002). Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg, 68, 827-31.
- Georgiades C, Geschwind JF, Harrison N, et al (2012). Lack of response after initial chemoembolization for hepatocellular carcinoma: dose it predict failure of subsequent treatment? Radiology, 265, 115-23. https://doi.org/10.1148/radiol.12112264
- Germani G, Pleguezuelo M, Gurusamy K, et al (2010). Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatoceluller carcinoma: a meta-analysis. J Hepatol, 52, 380-88. https://doi.org/10.1016/j.jhep.2009.12.004
- Jonggi C, Ju HS, Yong MS, et al (2014). Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular cacinama. J Hepatol, 60, 1212-18. https://doi.org/10.1016/j.jhep.2014.01.014
- Kang HK, Jeong YY, Choi JH, et al (2002). Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis. Radio Graphics, 22, 1053-61.
- Kim YS, Lim HK, Rhim H, et al (2013). Tenyear outcomes of percutaneous radiofrequency ablation as .rst-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol, 58, 89-97. https://doi.org/10.1016/j.jhep.2012.09.020
- Kosuke M, Toru B, Aikira C, et al (2013). Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of recurrence. Am Surg, 83, 1527-31.
- Lewandowski RJ, Geschwind JF, Liapi E, et al (2011). Transcatheter intraarterial therapies: rationale and overview. Radiology, 259, 641-57. https://doi.org/10.1148/radiol.11081489
- Lupo L, Panzera P, Giannelli G, et al (2007). Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford), 9, 429-34. https://doi.org/10.1080/13651820701713758
- Mark B, Odion B, Elie F, et al (2002). Transcatheter arterial chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy. Am Surg, 68, 827-31
- Martin RC, Robbins K, Tomalty D, et al (2009). Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol, 7, 80-92. https://doi.org/10.1186/1477-7819-7-80
- Michael V, Ali H, Thomas JW, et al (2014). Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology, 60, 192-201. https://doi.org/10.1002/hep.27057
- Nakai M, Shiraki T, Higashi K, et al (2005). Low-output radiofrequency ablation combined with transcatheter arterial oilychemoembolization for hepatocellur carcinoma. Nihon Lgaku Hoshasen Gakkai Zasshi, 65, 124-26.
- Pellerin O, Lin M, Bhagat N, et al (2013). Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis? Cancer Biother Radiopharm, 28, 459-65. https://doi.org/10.1089/cbr.2012.1390
- Salem R, Miller FH, Yaghmai V, et al (2013). Response assessment methodologies in hepatocellular carcinoma: complexities in the era of local and systemic treatments. J Hepatol, 58, 1260-62.
- Tacher V, Lin M, Chao M, et al (2013). Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad Radiol, 20, 446-52. https://doi.org/10.1016/j.acra.2012.11.009
- Vigano L, Ferrero A, Lo Tesoriere R, et al (2008). Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol, 15, 2458-64. https://doi.org/10.1245/s10434-008-9935-9
- Yang HJ, Lee JH, Lee DH, et al (2014). Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. Radiology, 271, 909-18. https://doi.org/10.1148/radiol.13131760
- Zhi VF, Francesco P, Laurence N, et al (2012). Combined Hepatic Arterial Embolization and Hepatic Ablation for Unresectable Colorectal Metastases to the liver. Am Surg, 78, 1243-48.
- Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
- A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485